Insider Transactions in Q4 2025 at Evoke Pharma Inc (EVOK)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2025
|
Nantahala Capital Management, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
148,153
-100.0%
|
$1,629,683
$11.0 P/Share
|
|
Dec 16
2025
|
Matthew J D'Onofrio Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,509
-100.0%
|
-
|
|
Dec 16
2025
|
Todd C Brady |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
27
-100.0%
|
-
|
|
Dec 16
2025
|
Mark Kowieski Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,815
-100.0%
|
-
|
|
Dec 16
2025
|
Malcolm R Hill |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
133
-100.0%
|
-
|
|
Dec 16
2025
|
Cam L Garner |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,330
-100.0%
|
-
|
|
Dec 16
2025
|
Marilyn R. Carlson Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
360
-100.0%
|
-
|
|
Nov 06
2025
|
Roger M. Klein > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,000
-8.9%
|
$90,000
$10.66 P/Share
|